glp-1 concentration metabolite GLP-1(9–36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion | Diabetologia Plasma GLP-1 concentrations during iv

Eur Heart J 31:773776 Noyan-Ashraf MH, Momen MA, Ban K, Sadi AM, Zhou YQ, Riazi AM et al (2009) GLP-1R agonist liraglutide activates cytoprotective pathways and improves outcomes after experimental myocardial infarction in mice

(Geriatrics/Internal Medicine/Family Medicine) Office visit for a 50-year-old female, established patient, seen for her gold injection by the nurse

1 Although oral and perioral pigmentation may be physiologic in nature, particularly in individuals with a darker complexion, throughout the course of disease it is possible for the oral mucosa and perioral tissues to assume a variety of discolorations, including brown, blue, gray, and black

This study not only provides real-world cost-effectiveness findings that complement evidence from trial- or model-based CEAs but also summarizes up-to-date cost-effectiveness evidence, both of which are of importance for clinical decision-making regarding treatment selections and the formulation of healthcare reimbursement policies in real-world practice

These findings suggest that disruption of the leptin-proopiomelanocortin-MC4R circuit is associated with reduced executive control over eating behavior (126)

Schoonjans, F